Stockreport

Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay® for the Treatment of Inflammatory Lesions of Rosacea

Sol-Gel Technologies Ltd.  (SLGL) 
Last sol-gel technologies ltd. earnings: 11/13 07:05 am Check Earnings Report
PDF - PDUFA Goal Date Set for April 26, 2021 - Potential to be first FDA-approved single-agent benzoyl peroxide prescription drug product NESS ZIONA, Israel, Sept. 10, 20 [Read more]